Phase I Study of Vandetanib With Radiation Therapy With or Without Cisplatin in Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck - United States
doi 10.1002/hed.23922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nimotuzumab With Concurrent Chemo-Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN)

Journal of Cancer Therapy
2015English

Phase I Trial of Concomitant Hyperfractionated Radiotherapy With Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

Cancer Journal
Cancer ResearchOncology
2006English

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study

Oncologist
Cancer ResearchMedicineOncology
2016English

Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2011English

Radiotherapy for the Management of Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Oral Diseases
OtorhinolaryngologyDentistry
2009English

Patterns of Recurrence After Selective Postoperative Radiation Therapy for Patients With Head and Neck Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

A Phase II Evaluation of a 3-Hour Infusion of Paclitaxel, Cisplatin, and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Cancer
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy